These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 31791672)
1. Brain Foxp3 Guo S; Luo Y Int Immunopharmacol; 2020 Apr; 81():106027. PubMed ID: 31791672 [TBL] [Abstract][Full Text] [Related]
2. The role of Interleukin-33 in the modulation of splenic T-cell immune responses after experimental ischemic stroke. Xiao W; Guo S; Chen L; Luo Y J Neuroimmunol; 2019 Aug; 333():576970. PubMed ID: 31146104 [TBL] [Abstract][Full Text] [Related]
3. Promoted Generation of T Helper 1-Like Regulatory T Cells After Transient Middle Cerebral Artery Occlusion in Type-2 Diabetic Mice. Jian L; Hu Y; Gao M; Shu L Immunol Invest; 2023 Nov; 52(4):482-498. PubMed ID: 37076315 [TBL] [Abstract][Full Text] [Related]
4. Amphiregulin Confers Regulatory T Cell Suppressive Function and Tumor Invasion via the EGFR/GSK-3β/Foxp3 Axis. Wang S; Zhang Y; Wang Y; Ye P; Li J; Li H; Ding Q; Xia J J Biol Chem; 2016 Sep; 291(40):21085-21095. PubMed ID: 27432879 [TBL] [Abstract][Full Text] [Related]
5. The ST2 Wachtendorf S; Jonin F; Ochel A; Heinrich F; Westendorf AM; Tiegs G; Neumann K Front Immunol; 2024; 15():1351405. PubMed ID: 38571949 [TBL] [Abstract][Full Text] [Related]
6. Expression and regulation of miR-449a and AREG in cerebral ischemic injury. Yu Y; Zhang X; Han Z; Zhao W; Zhang L Metab Brain Dis; 2019 Jun; 34(3):821-832. PubMed ID: 30773606 [TBL] [Abstract][Full Text] [Related]
7. Regulatory T cell is critical for interleukin-33-mediated neuroprotection against stroke. Liu X; Hu R; Pei L; Si P; Wang C; Tian X; Wang X; Liu H; Wang B; Xia Z; Xu Y; Song B Exp Neurol; 2020 Jun; 328():113233. PubMed ID: 32044328 [TBL] [Abstract][Full Text] [Related]
8. Albumin induces neuroprotection against ischemic stroke by altering Toll-like receptor 4 and regulatory T cells in mice. Wang M; Wang Y; He J; Wei S; Zhang N; Liu F; Liu X; Kang Y; Yao X CNS Neurol Disord Drug Targets; 2013 Mar; 12(2):220-7. PubMed ID: 23394540 [TBL] [Abstract][Full Text] [Related]
9. Rorc restrains the potency of ST2+ regulatory T cells in ameliorating intestinal graft-versus-host disease. Yang J; Ramadan A; Reichenbach DK; Loschi M; Zhang J; Griesenauer B; Liu H; Hippen KL; Blazar BR; Paczesny S JCI Insight; 2019 Mar; 4(5):. PubMed ID: 30694220 [TBL] [Abstract][Full Text] [Related]
10. Regulatory T cells increase after treatment with poly (ADP-ribose) polymerase-1 inhibitor in ischemic stroke patients. Noh MY; Lee WM; Lee SJ; Kim HY; Kim SH; Kim YS Int Immunopharmacol; 2018 Jul; 60():104-110. PubMed ID: 29709770 [TBL] [Abstract][Full Text] [Related]
11. Zhang H; Xia Y; Ye Q; Yu F; Zhu W; Li P; Wei Z; Yang Y; Shi Y; Thomson AW; Chen J; Hu X J Neurosci; 2018 Nov; 38(47):10168-10179. PubMed ID: 30291203 [TBL] [Abstract][Full Text] [Related]
12. Brain regulatory T cells suppress astrogliosis and potentiate neurological recovery. Ito M; Komai K; Mise-Omata S; Iizuka-Koga M; Noguchi Y; Kondo T; Sakai R; Matsuo K; Nakayama T; Yoshie O; Nakatsukasa H; Chikuma S; Shichita T; Yoshimura A Nature; 2019 Jan; 565(7738):246-250. PubMed ID: 30602786 [TBL] [Abstract][Full Text] [Related]
13. IL-33 is an unconventional Alarmin that stimulates IL-2 secretion by dendritic cells to selectively expand IL-33R/ST2+ regulatory T cells. Matta BM; Lott JM; Mathews LR; Liu Q; Rosborough BR; Blazar BR; Turnquist HR J Immunol; 2014 Oct; 193(8):4010-20. PubMed ID: 25217167 [TBL] [Abstract][Full Text] [Related]
14. Amphiregulin enhances regulatory T cell-suppressive function via the epidermal growth factor receptor. Zaiss DM; van Loosdregt J; Gorlani A; Bekker CP; Gröne A; Sibilia M; van Bergen en Henegouwen PM; Roovers RC; Coffer PJ; Sijts AJ Immunity; 2013 Feb; 38(2):275-84. PubMed ID: 23333074 [TBL] [Abstract][Full Text] [Related]
15. Cryptotanshinone possesses therapeutic effects on ischaemic stroke through regulating STAT5 in a rat model. Zhu F; Chen H; Xu M; Zhang X; Yu J; Pan Y; Zhu W Pharm Biol; 2021 Dec; 59(1):465-471. PubMed ID: 33915069 [TBL] [Abstract][Full Text] [Related]
16. Interleukin-33 ameliorates ischemic brain injury in experimental stroke through promoting Th2 response and suppressing Th17 response. Luo Y; Zhou Y; Xiao W; Liang Z; Dai J; Weng X; Wu X Brain Res; 2015 Feb; 1597():86-94. PubMed ID: 25500143 [TBL] [Abstract][Full Text] [Related]
17. Cerebral ischemia increases bone marrow CD4+CD25+FoxP3+ regulatory T cells in mice via signals from sympathetic nervous system. Wang J; Yu L; Jiang C; Fu X; Liu X; Wang M; Ou C; Cui X; Zhou C; Wang J Brain Behav Immun; 2015 Jan; 43():172-83. PubMed ID: 25110149 [TBL] [Abstract][Full Text] [Related]
18. IL-33 Effect on Quantitative Changes of CD4 Ryba-Stanisławowska M; Werner P; Skrzypkowska M; Brandt A; Myśliwska J Mediators Inflamm; 2016; 2016():9429760. PubMed ID: 27761063 [TBL] [Abstract][Full Text] [Related]
19. Exercise preconditioning attenuates cerebral ischemia-induced neuronal apoptosis, Th17/Treg imbalance, and inflammation in rats by inhibiting the JAK2/STAT3 pathway. Shan Y; Wang L; Sun J; Chang S; Di W; Lv H Brain Behav; 2023 Jun; 13(6):e3030. PubMed ID: 37143406 [TBL] [Abstract][Full Text] [Related]
20. Ex vivo expansion of CD4+CD25+FoxP3+ T regulatory cells based on synergy between IL-2 and 4-1BB signaling. Elpek KG; Yolcu ES; Franke DD; Lacelle C; Schabowsky RH; Shirwan H J Immunol; 2007 Dec; 179(11):7295-304. PubMed ID: 18025172 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]